2 items2 sources3 stocks
Yahoo Finance-Sep 4, 04:22 AM
Why Did NIO, RARE, MCD Stocks Fall To 52-Week Lows?
NIO stock fell to a 52-week low after Q2 earnings missed expectations and the company issued softer-than-expected Q3 guidance, accompanied by analyst downgrades. RARE plunged 44% after its Phase 3 ASPIRE Angelman study failed to meet both primary and secondary endpoints.
Why it matters: MCD declined as weaker second-quarter revenue and slower U.S. customer traffic pressured the stock.
GlobeNewswire-Sep 2, 08:01 PM
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome（摘要待生成）